US Stock MarketDetailed Quotes

NUV Nuveen Municipal Value Fund Inc

Watchlist
  • 8.590
  • +0.010+0.12%
Close Jan 13 16:00 ET
1.78BMarket Cap8.95P/E (TTM)

Nuveen Municipal Value Fund Inc Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Oct 31, 2024
(FY)Oct 31, 2023
(FY)Oct 31, 2022
(FY)Oct 31, 2021
(FY)Oct 31, 2020
(FY)Oct 31, 2019
(FY)Oct 31, 2018
(FY)Oct 31, 2017
Total revenue
259.43%200.53M
117.81%55.79M
-403.95%-313.3M
71.29%103.08M
-73.83%60.17M
1,860.80%229.9M
-121.07%-13.06M
61.98M
Net interest income
3.52%84.32M
27,528.00%81.46M
-68.55%-296.98K
50.52%-176.2K
52.40%-356.07K
-8.77%-748K
-348.05%-687.69K
---153.49K
-Net interest income
4.00%85.53M
--82.25M
--0
--0
--0
--0
--0
--0
-Total interest expense
52.68%1.21M
166.54%791.58K
68.55%296.98K
-50.52%176.2K
-52.40%356.07K
8.77%748K
348.05%687.69K
--153.49K
Non interest income
552.80%116.21M
91.80%-25.66M
-403.15%-313.01M
70.58%103.25M
-73.76%60.53M
1,964.74%230.64M
-119.91%-12.37M
--62.13M
-Fees and commissions
-1.99%-8.77M
1.73%-8.6M
7.19%-8.75M
1.05%-9.43M
0.27%-9.53M
-1.22%-9.56M
2.20%-9.44M
---9.65M
-Dividend income
--0
----
----
----
----
----
----
----
Credit losses provision
Non interest expense
Selling and administrative expenses
28.01%705.39K
-22.78%551.04K
-0.37%713.56K
-10.64%716.2K
-4.72%801.47K
4.63%841.2K
-18.68%804K
--988.68K
-General and administrative expense
28.01%705.39K
-22.78%551.04K
-0.37%713.56K
-10.64%716.2K
-4.72%801.47K
4.63%841.2K
-18.68%804K
--988.68K
Income from associates and other participating interests
Special income (charges)
0
Less:Restructuring and mergern&acquisition
----
----
----
--0
----
----
----
----
Other non-operating income (expenses)
Income before tax
261.93%198.84M
117.48%54.94M
-408.14%-314.33M
72.77%102.01M
-74.18%59.05M
1,704.92%228.66M
-123.46%-14.25M
60.74M
Income tax
Earnings from equity interest net of tax
Net income
261.93%198.84M
117.48%54.94M
-408.14%-314.33M
72.77%102.01M
-74.18%59.05M
1,704.92%228.66M
-123.46%-14.25M
60.74M
Net Income continuous operations
261.93%198.84M
117.48%54.94M
-408.14%-314.33M
72.77%102.01M
-74.18%59.05M
1,704.92%228.66M
-123.46%-14.25M
--60.74M
Minority interest income
Net income attributable to the parent company
261.93%198.84M
117.48%54.94M
-408.14%-314.33M
72.77%102.01M
-74.18%59.05M
1,704.92%228.66M
-123.46%-14.25M
60.74M
Preferred stock dividends
Other preferred stock dividend
Net income attributable to common stockholders
261.93%198.84M
117.48%54.94M
-408.14%-314.33M
72.77%102.01M
-74.18%59.05M
1,704.92%228.66M
-123.46%-14.25M
60.74M
Basic earnings per share
269.23%0.96
117.22%0.26
-402.00%-1.51
78.57%0.5
-74.55%0.28
1,671.43%1.1
-123.33%-0.07
0.3
Diluted earnings per share
269.23%0.96
117.22%0.26
-402.00%-1.51
78.57%0.5
-74.55%0.28
1,671.43%1.1
-123.33%-0.07
0.3
Dividend per share
4.73%0.354
0.60%0.338
-5.88%0.336
-4.03%0.357
0.00%0.372
0.00%0.372
-4.62%0.372
0.39
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
Unqualified Opinion
Unqualified Opinion
Unqualified Opinion
Unqualified Opinion
Unqualified Opinion
Unqualified Opinion
Unqualified Opinion
Unqualified Opinion
(FY)Oct 31, 2024(FY)Oct 31, 2023(FY)Oct 31, 2022(FY)Oct 31, 2021(FY)Oct 31, 2020(FY)Oct 31, 2019(FY)Oct 31, 2018(FY)Oct 31, 2017
Total revenue 259.43%200.53M117.81%55.79M-403.95%-313.3M71.29%103.08M-73.83%60.17M1,860.80%229.9M-121.07%-13.06M61.98M
Net interest income 3.52%84.32M27,528.00%81.46M-68.55%-296.98K50.52%-176.2K52.40%-356.07K-8.77%-748K-348.05%-687.69K---153.49K
-Net interest income 4.00%85.53M--82.25M--0--0--0--0--0--0
-Total interest expense 52.68%1.21M166.54%791.58K68.55%296.98K-50.52%176.2K-52.40%356.07K8.77%748K348.05%687.69K--153.49K
Non interest income 552.80%116.21M91.80%-25.66M-403.15%-313.01M70.58%103.25M-73.76%60.53M1,964.74%230.64M-119.91%-12.37M--62.13M
-Fees and commissions -1.99%-8.77M1.73%-8.6M7.19%-8.75M1.05%-9.43M0.27%-9.53M-1.22%-9.56M2.20%-9.44M---9.65M
-Dividend income --0----------------------------
Credit losses provision
Non interest expense
Selling and administrative expenses 28.01%705.39K-22.78%551.04K-0.37%713.56K-10.64%716.2K-4.72%801.47K4.63%841.2K-18.68%804K--988.68K
-General and administrative expense 28.01%705.39K-22.78%551.04K-0.37%713.56K-10.64%716.2K-4.72%801.47K4.63%841.2K-18.68%804K--988.68K
Income from associates and other participating interests
Special income (charges) 0
Less:Restructuring and mergern&acquisition --------------0----------------
Other non-operating income (expenses)
Income before tax 261.93%198.84M117.48%54.94M-408.14%-314.33M72.77%102.01M-74.18%59.05M1,704.92%228.66M-123.46%-14.25M60.74M
Income tax
Earnings from equity interest net of tax
Net income 261.93%198.84M117.48%54.94M-408.14%-314.33M72.77%102.01M-74.18%59.05M1,704.92%228.66M-123.46%-14.25M60.74M
Net Income continuous operations 261.93%198.84M117.48%54.94M-408.14%-314.33M72.77%102.01M-74.18%59.05M1,704.92%228.66M-123.46%-14.25M--60.74M
Minority interest income
Net income attributable to the parent company 261.93%198.84M117.48%54.94M-408.14%-314.33M72.77%102.01M-74.18%59.05M1,704.92%228.66M-123.46%-14.25M60.74M
Preferred stock dividends
Other preferred stock dividend
Net income attributable to common stockholders 261.93%198.84M117.48%54.94M-408.14%-314.33M72.77%102.01M-74.18%59.05M1,704.92%228.66M-123.46%-14.25M60.74M
Basic earnings per share 269.23%0.96117.22%0.26-402.00%-1.5178.57%0.5-74.55%0.281,671.43%1.1-123.33%-0.070.3
Diluted earnings per share 269.23%0.96117.22%0.26-402.00%-1.5178.57%0.5-74.55%0.281,671.43%1.1-123.33%-0.070.3
Dividend per share 4.73%0.3540.60%0.338-5.88%0.336-4.03%0.3570.00%0.3720.00%0.372-4.62%0.3720.39
Currency Unit USDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions Unqualified OpinionUnqualified OpinionUnqualified OpinionUnqualified OpinionUnqualified OpinionUnqualified OpinionUnqualified OpinionUnqualified Opinion
Trending US Stocks
Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Symbol Mini Chart % Chg
LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
+4.06%
DexCom
DXCM
+2.67%
Collegium Pharmaceutical
COLL
+2.67%
Halozyme Therapeutics
HALO
+2.54%
Constellation Brands
STZ
+2.26%

Unlock the Full List